Clinical Trial Update: Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients

View source ↗

Summary

This clinical trial update notes completion of a study evaluating whether EGFR methylation affects cetuximab response in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Colon Cancer Adenocarcinoma | Status: COMPLETED